ARRIS price target raised to $40 from $33 at Brean Capital Brean Capital raised its price target on ARRIS to $40 from $33 as current sales and earnings momentum is likely to continue into next year. The firm sees continued pay down of debt, market share gains, and a favorable macro outlook and keeps it Buy rating on the stock.
ARRIS acquisition of Pace receives antitrust clearance from Colombia ARRIS Group announced that its proposed acquisition of Pace received unconditional merger clearance from The Superintendence of Industry and Commerce in Colombia. This clearance follows pre-conditional clearance in Germany, South Africa, and Portugal. Completion of the transaction remains subject to the expiration or termination of the waiting period under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the satisfaction of similar merger control requirements in Brazil, together with satisfaction of other customary closing conditions.